
zzso reduction therapy zzso is considered to be a potential therapeutic option for juvenile zzso zzso zzso We evaluated the efficacy of zzso in zzso assessing zzso zzso and brain magnetic resonance imaging zzso outcomes over a zzso period of zzso In an zzso and zzso study, five zzso patients zzso age zzso zzso received oral zzso at doses of zzso zzso adjusted to body surface zzso Patients underwent general and neurological zzso zzso zzso and brain zzso zzso All patients showed neurological deterioration over the period of the study, with particularly notable worsening of zzso speech and zzso One patient experienced acute zzso and another showed worsening of pre-existing zzso Some zzso tests showed no evidence of deterioration in the three patients with high enough cognitive functioning for reliable zzso zzso cognitive impairment in two children precluded zzso zzso In four patients, evaluation of brain zzso showed no changes in white matter signal abnormalities and zzso zzso noted at zzso while one patient showed progression of zzso and zzso brain zzso zzso electron zzso analysis of peripheral zzso cells showed reduction of zzso inclusions with zzso zzso with zzso of patients with zzso failed to zzso progressive neurological zzso but apparently no worsening of some areas of cognitive function tested and brain zzso zzso was noted over 24 months of zzso The results must be interpreted with care zzso to the small sample of patients and the lack of a zzso 

